Geriatric Assessment Predictors of 1-Year Mortality in Older Adults With GI Malignancies: A Survival Tree Analysis.
Journal
JCO clinical cancer informatics
ISSN: 2473-4276
Titre abrégé: JCO Clin Cancer Inform
Pays: United States
ID NLM: 101708809
Informations de publication
Date de publication:
09 2022
09 2022
Historique:
entrez:
7
9
2022
pubmed:
8
9
2022
medline:
11
9
2022
Statut:
ppublish
Résumé
Identifying older patients with GI malignancies who are at increased risk of mortality remains challenging. The goal of our study was to examine geriatric assessment (GA) predictors of 1-year mortality and explore the use of a survival tree analysis in a prospective cohort of older adults (≥ 60 years) with newly diagnosed GI malignancies. Survival tree analysis was performed to understand variable interactions and identify predictors of overall survival, computed from time of GA to death or last follow-up. Cox regression was used to estimate associations of 1-year mortality, first using a base model (age, race, cancer stage, cancer risk group, and planned chemotherapy), then using all significant predictors from the univariable analyses, and finally only those identified in survival tree analysis. A total of 478 participants met eligibility, with a mean age of 70 years. The survival tree analysis identified nutrition, cancer stage, physical and emotional health, age, and functional status as predictors of mortality. Older patients without malnutrition or depression had the best 1-year survival, whereas those with malnutrition, stage IV disease, and functional limitations had the worst 1-year survival. Our base model demonstrated good discrimination (area under curve [AUC] 0.76) but was improved with the addition of GA variables (AUC 0.82) or from survival tree analysis (AUC 0.82). Measures of function, nutrition, and mental health are important predictors of mortality in older adults with GI cancers. Using GA as part of clinical management can aid in the prediction of survival and help inform treatment decision making.
Identifiants
pubmed: 36070529
doi: 10.1200/CCI.22.00065
pmc: PMC9470132
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
e2200065Subventions
Organisme : NCI NIH HHS
ID : K08 CA234225
Pays : United States
Références
J Clin Oncol. 2009 Jun 10;27(17):2758-65
pubmed: 19403886
Qual Life Res. 2009 Sep;18(7):873-80
pubmed: 19543809
J Transl Med. 2017 Nov 28;15(1):240
pubmed: 29183386
Cancer. 2005 Nov 1;104(9):1998-2005
pubmed: 16206252
J Natl Compr Canc Netw. 2021 Sep 20;19(9):1006-1019
pubmed: 34551388
Oncologist. 2015 Apr;20(4):379-85
pubmed: 25765876
J Geriatr Oncol. 2020 Mar;11(2):270-273
pubmed: 31005648
J Geriatr Oncol. 2022 Mar;13(2):176-181
pubmed: 34483079
J Geriatr Oncol. 2017 Jul;8(4):249-254
pubmed: 28285980
Eur J Cancer. 2018 Sep;100:65-74
pubmed: 30014882
CA Cancer J Clin. 2021 Jan;71(1):7-33
pubmed: 33433946
J Gerontol A Biol Sci Med Sci. 2015 Sep;70(9):1148-55
pubmed: 25834194
J Clin Oncol. 2011 Apr 1;29(10):1290-6
pubmed: 21357782
J Natl Compr Canc Netw. 2021 Jun 11;19(8):922-927
pubmed: 34116502
JCO Oncol Pract. 2021 Jun;17(6):336-344
pubmed: 33064058
Oncologist. 2022 Feb 3;27(1):e45-e52
pubmed: 35305105
J Geriatr Oncol. 2020 Mar;11(2):203-211
pubmed: 31451439
J Geriatr Oncol. 2014 Jul;5(3):245-51
pubmed: 24703978
J Geriatr Oncol. 2018 Jul;9(4):329-336
pubmed: 29426572
J Clin Oncol. 2020 Aug 1;38(22):2558-2569
pubmed: 32250717
J Clin Oncol. 2018 Aug 1;36(22):2326-2347
pubmed: 29782209